| Thu, Dec 17, 2009 | | | Chinese Outsourcer Of Clinical Trials Tries To Spread Its Wings Investor's Business Daily (Thu, Dec 17)
| | Wed, Dec 9, 2009 | | | Interview With Douglas C. Maclellan - CEO Of ADML Wall Street Transcript (Wed, Dec 9)
| | Tue, Dec 8, 2009 | | | China Growth Stock Portfolio Created From Bottom Up By Experienced Asset Manager Wall Street Transcript (Tue, Dec 8)
| | Mon, Dec 7, 2009 | | | Generic Prescription Expansion Accelerates Under New Health Care Reform Regime Adding Margin To Pharmacies And PBMs Says Leading Industry Expert Wall Street Transcript (Mon, Dec 7)
| | | WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening PR Newswire (Mon, Dec 7)
| | Mon, Nov 30, 2009 | | | WuXi Pharmatech, QAD: Biggest Price Gainers (WX, QADI) at The Wall Street Journal Online (Mon, Nov 30)
| | | WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year PR Newswire (Mon, Nov 30)
| | Wed, Nov 25, 2009 | | | We Expect Ailing CROs to Recover Morningstar.com (Wed, Nov 25)
| | Wed, Nov 18, 2009 | | | Wuxo PharmaTech Reports Stellar Earnings at Seeking Alpha (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | | WuXi PharmaTech Co., Ltd. Earnings Call scheduled for 8:00 am ET today CCBN (Tue, Nov 17)
| | | Q3 2009 WuXi PharmaTech Co., Ltd. Earnings Release - Before Market Open CCBN (Tue, Nov 17)
| | | WuXi Pharma Feels the Worst of the Downturn Is Over at Seeking Alpha (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | | WuXi PharmaTech Announces Third-Quarter 2009 Results PR Newswire (Mon, Nov 16)
| | | WuXi PharmaTech downgraded by Credit Suisse Briefing.com (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | | WuXi Pharma Planning New Facility for R&D Services at Seeking Alpha (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | | How Do You Say 'Drug Development' in Mandarin? at Motley Fool (Thu, Nov 12)
| | | 3 Stocks Hitting High Notes at Motley Fool (Thu, Nov 12)
| | Sun, Nov 8, 2009 | | | The Buying Opportunity You Won't Want to Miss at Motley Fool (Sun, Nov 8)
| | Fri, Nov 6, 2009 | | | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors Wall Street Transcript (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | | Chinese Companies Traded On US Stock Exchanges Provide Deep Value For Investors According To First Wilshire Securities Wall Street Transcript (Thu, Nov 5)
| Add WX News to My Yahoo!:

| |
|